
iDEL Therapeutics
Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells.
About
iDEL Therapeutics is a Dortmund-based startup focused on developing novel cancer therapeutics. Their core technology is a synthetic shuttle platform designed to deliver drugs directly into the cytosol of tumor cells, evading endosomal trapping and preventing degradation. This platform is compatible with both large and small molecules, including nanobodies and cytotoxic payloads, aiming to unlock historically undruggable intracellular targets and broaden therapeutic windows.
Show 6 more similar companies
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Biotechnology company developing and commercializing cell therapies for cancer treatment.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Oncology
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to iDEL Therapeutics?
People comparing tools land here. Get listed beside these.
All funding rounds
Tech stack
Detected on idel-tx.com, last scanned 1 Nov 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Benchmarking
See how your site ranks against 16,849 startups
iDEL Therapeutics sits in the 19th percentile for Domain Rating. Check where yours lands, free.
Check your Domain RatingiDEL Therapeutics has a Domain Rating of 12, the 19th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Bottom 25%
Check yoursAgent Readiness
Bottom 25%
Scan yoursSite Speed
Bottom 25%
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
iDEL Therapeutics scores 21. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentAI visibility
Get read by ChatGPT, Claude and Perplexity
List your startup, then track where you show up in AI answers.
AI reads of this profile
Last 14 days, from server logs
Get notified when iDEL Therapeutics changes
Used iDEL Therapeutics? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Is iDEL Therapeutics growing?
Yes, fast. Our data shows it raised $9.7M in a Seed in March 2026.
Are there companies like iDEL Therapeutics?
Yes. We list 6 companies like iDEL Therapeutics, including Moderna, Kite Pharma and Degron Therapeutics.
What does iDEL Therapeutics do?
The company is advancing two proprietary lead programs towards clinical evaluation, with a focus on addressing a range of solid tumors. iDEL Therapeutics also aims to create scalable value through partnerships.
Is iDEL Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for iDEL Therapeutics is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has iDEL Therapeutics raised?
iDEL Therapeutics has raised a total of $10M in funding. The most recent round on record is Seed.
SEC filings, insider activity, nonprofit links and pay benchmarks for iDEL Therapeutics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch iDEL Therapeutics and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


